Physiological microassay of plasma total antioxidant status in a model of endothelial dysfunction in the rat following experimental oxidant stress in vivo

被引:33
作者
Laight, DW [1 ]
Gunnarsson, PT [1 ]
Kaw, AV [1 ]
Änggård, EE [1 ]
Carrier, MJ [1 ]
机构
[1] St Bartholomews & Royal London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England
关键词
endothelium; nitric oxide; rat aorta; oxidant stress; antioxidant status;
D O I
10.1016/S1382-6689(98)00046-5
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
We have developed a photometric microassay for the assessment of total antioxidant status in plasma at physiological pH and temperature and applied it to evaluate experimental oxidant stress in vivo associated with endothelial dysfunction in vitro. Rat plasma or L-ascorbic acid inhibited the peroxidase-mediated accumulation after 6 min at pH 7.4 and 37 degrees C of ABTS(+) (2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) radical), measured at 405 nm, in a concentration-dependent manner. Plasma total antioxidant status, expressed as the ascorbate equivalent antioxidant concentration, was subsequently found to be significantly reduced in rats treated daily for 7 days in vivo with the oxidant compounds hydroquinone (50 mg/kg i.p.) and triethylenetetramine (100 mg/kg i.p.), either alone or in combination with the glutathione-depleting agent L-buthionine sulfoximine (50 mg/kg i.p). Furthermore, basal endothelial function in isolated aorta was impaired after hydroquinone or triethylenetetramine in a manner aggravated by L-buthionine sulfoximine. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 23 条
[1]   Inhibition by L-ascorbic acid and other antioxidants of the 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) oxidation catalyzed by peroxidase: A new approach for determining total antioxidant status of foods [J].
Arnao, MB ;
Cano, A ;
HernandezRuiz, J ;
GarciaCanovas, F ;
Acosta, M .
ANALYTICAL BIOCHEMISTRY, 1996, 236 (02) :255-261
[2]   IN-VIVO SELECTIVE MODULATION OF TISSUE GLUTATHIONE IN A RAT MAMMARY-CARCINOMA MODEL [J].
BARUCHEL, S ;
WANG, TQ ;
FARAH, R ;
JAMALI, M ;
BATIST, G .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (09) :1505-1508
[3]   Effect of L-buthionine-(S,R)-sulphoximine, an inhibitor of γ-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure [J].
Cuzzocrea, S ;
Zingarelli, B ;
O'Connor, M ;
Salzman, AL ;
Szabó, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (03) :525-537
[4]  
DeMan JG, 1996, BRIT J PHARMACOL, V119, P1022
[5]  
FLOREANI M, 1991, J PHARMACOL EXP THER, V260, P468
[6]   Effect of percutaneous absorption of fluocinolone acetonide on the activity of superoxide dismutase and total antioxidant status in patients with psoriasis [J].
Gavan, N ;
Popa, R ;
Orasan, R ;
Maibach, H .
SKIN PHARMACOLOGY, 1997, 10 (04) :178-182
[7]   Appendicitis after laparoscopic appendectomy: A warning [J].
Greenberg, JJ ;
Esposito, TJ .
JOURNAL OF LAPAROENDOSCOPIC SURGERY, 1996, 6 (03) :185-187
[8]   SUPEROXIDE ANION IS INVOLVED IN THE BREAKDOWN OF ENDOTHELIUM-DERIVED VASCULAR RELAXING FACTOR [J].
GRYGLEWSKI, RJ ;
PALMER, RMJ ;
MONCADA, S .
NATURE, 1986, 320 (6061) :454-456
[9]  
Halliwell B., 1991, AM J MED, V91, P14, DOI DOI 10.1016/0002-9343(91)90279-7
[10]   Interaction between superoxide anion and nitric oxide in the regulation of vascular endothelial function [J].
Laight, DW ;
Kaw, AV ;
Carrier, MJ ;
Ånggård, EE .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (01) :238-244